Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

579 Articles

Lee Jackson | Jun 15, 2018 at 10:07 AM EDT

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a…

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

Lee Jackson | Jun 1, 2018 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines…

Lee Jackson | May 30, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Apple, Broadcom, Exxon Mobil, Fabrinet, HP, Match…

Chris Lange | May 25, 2018 at 9:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 1, 2018 at 10:50 AM EDT

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

AbbVie is trying one of the older and less-used efforts to drive its share price back up: a modified Dutch…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 22, 2018 at 10:15 AM EDT

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and…

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Mar 26, 2018 at 4:08 PM EDT

Monday’s Biggest Winners and Losers in the S&P 500

Monday was an incredible day for the broad U.S. markets, with the Dow posting one of its top 3 performances,…

Chris Lange | Mar 24, 2018 at 8:25 AM EDT

How Analysts See AbbVie After the Big Disappointment

AbbVie shares took a big step back last week after the firm reported less than favorable results for its relapsed/refractory…

Jon C. Ogg | Mar 23, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron…

1 … 19 20 21 22 23 … 39

AbbVie : ABBV

All AbbVie Articles

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Major Pharmaceuticals Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

Major Pharma Short Sellers Grow More Selective

Short Sellers Run for Cover From Major Pharma

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

Short Sellers Grow More Selective on Major Pharma Stocks

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Monday’s Biggest Winners and Losers in the S&P 500

How Analysts See AbbVie After the Big Disappointment

Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

AbbVie : ABBV

All AbbVie Articles

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Major Pharmaceuticals Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

Major Pharma Short Sellers Grow More Selective

Short Sellers Run for Cover From Major Pharma

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

Short Sellers Grow More Selective on Major Pharma Stocks

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Monday’s Biggest Winners and Losers in the S&P 500

How Analysts See AbbVie After the Big Disappointment

Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It